Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
516.00    2.00 (0.39%)
Bid:
514.00
Ask:
518.00
Spread: 4.00 (0.778%)
Market Cap: £853.03m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Results analysis from Kepler Trust Intelligence

11 Mar 2022 09:08

RNS Number : 4996E
Oakley Capital Investments Limited
11 March 2022
 

Oakley Capital Investments (OCI)

11/03/2022

 

Results analysis from Kepler Trust Intelligence

Oakley Capital Investments (OCI) announced its final results for the year ended 31 December 2021, in which strong earnings and realisations drove significant NAV growth of 35% on a total return basis, and a share price total return of 48%.

76% of the increase in the portfolio's value was driven by earnings growth, with underlying investments maintaining their pattern of strong growth. Average EBITDA growth over the year was 28%, underpinned by digitally enabled businesses and recurring revenues.

Oakley Fund commitments at the year-end were £404m, increasing to £740m when including the initial commitment to Fund V announced post year-end. The Chairman states that "With…a rich pipeline in place, OCI has the resources to help finance new Fund investments in the coming years, using balance sheet cash as well as proceeds from anticipated future realisations".

 

Kepler View

Oakley Capital Investments (OCI) offers a concentrated, but unique exposure to a number of very interesting growth companies. Certainly, the world has changed markedly from the year end date, but the underlying themes which have driven such strong earnings growth over the last year, seem unlikely to be derailed. At the year end, the portfolio exposure to consumer companies lay at 44%, with the rest of the portfolio relatively evenly balanced between technology and education.

When compared to the LPE peer group, OCI is relatively highly committed as a proportion of NAV. However, on the same day as the results announcement, the board announced they had authorised a buyback programme up to an aggregate consideration of £20 million, potentially an indication of the value they see in the shares (currently at a c. 30% discount to NAV), and their confidence on their balance sheet position.

Oakley Capital's focus on active management and value creation has helped its tech-enabled portfolio to continue generating strong earnings growth. Its unique deal sourcing network means they are able to find promising investments at attractive valuations. In the current period of geopolitical, market and economic volatility, we share the board's confidence in Oakley's "capabilities as a leading private equity investor, as well as the long-term potential of the Oakley Funds, to continue generating superior returns for investors" which have delivered a five-year compound annual growth rate of 19%.

OCI's shares have de-rated with the market this year, and now trade at a discount to the 31/12/2021 NAV of c. 30%. One change this year is the move to quarterly NAV announcements, the first of which is expected to be announced on 27 April 2022 (for the NAV as at 31/03/2022)…

CLICK HERE TO READ THE FULL REPORT

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGCGDXXGBDGDB
Date   Source Headline
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20207:33 amRNSResults analysis from Kepler Trust Intelligence
12th Mar 20207:00 amRNSFinal Annual Results 2019
4th Mar 20207:00 amRNSAcquisition of Globe-Trotter
24th Feb 20207:00 amRNSOakley agrees sale of atHome
30th Jan 20207:00 amRNSDirector Dealing
29th Jan 20207:00 amRNSTrading update for the year ended 31 December 2019
24th Dec 20199:00 amRNSUpdate on Rastreator and Acierto
23rd Dec 20193:06 pmRNSHolding(s) in Company
20th Dec 20194:52 pmRNSDirector/PDMR Shareholding
20th Dec 20193:42 pmRNSTransaction in Own Shares
20th Dec 20192:27 pmRNSShare Buy-Back
16th Dec 20197:00 amRNSAppointment of Non-Executive Director
12th Dec 20197:00 amRNSOakley agrees sale of WebPros to CVC
3rd Dec 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNSDirector Dealing
15th Nov 20197:00 amRNSDirector Dealing
14th Nov 20193:45 pmRNSTransaction in Own Shares
14th Nov 20197:00 amRNSShare Buy-back
18th Oct 20194:58 pmRNSHolding(s) in Company
13th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSResults for the six months ended 30 June 19
29th Aug 20197:00 amRNSInvestment in leading design company Alessi
23rd Aug 20198:00 amRNSAdmission to the Specialist Fund Segment
23rd Aug 20197:00 amRNSResult of Annual General Meeting
20th Aug 20195:30 pmRNSOakley Capital Investments
15th Aug 20197:00 amRNSAcquisition of Seven Miles
26th Jul 20197:00 amRNSNotice of AGM
24th Jul 20197:00 amRNSTrading update for the six months ended 30 June 19
18th Jul 20196:11 pmRNSPublication of Prospectus
18th Jul 20197:01 amRNSProposed move to SFS & AIM cancellation
18th Jul 20197:00 amRNSDirectorate Change
20th Jun 201912:50 pmRNSAnnual Report and Accounts and Shares in Issue
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
30th May 20197:00 amRNSInspired welcomes Warburg Pincus as an Investor
13th May 201911:52 amRNSAcquisition of Videotel and Seagull
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.